China Sees First Attack On ‘Morning-After’ Pill Under ‘One-Child’ Policy
This article was originally published in PharmAsia News
Executive Summary
The “morning-after” pill in China, almost a common drug at this point in a 30-year national “one-child” policy, has become controversial since a provincial capital required detailed identification of women buying the protection.